Canadian healthcare capacity gaps for disease-modifying treatment in Huntington’s disease: a survey of current practice and modelling of future needs

• Sylvain Chouinard,
• Blair R Leavitt,
• Angèle Bénard,
• Nathalie Budd,
• Jennifer W Wu,
• Kerrie Schoffer

Affiliations

Sylvain Chouinard

9 Department of Movement Disorders, Centre Hospitalier Universitaire de Montréal-Hôtel Dieu, CHUM, Montréal, QC, Canada

Blair R Leavitt

9Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Canada

Angèle Bénard

Huntington Society of Canada, Waterloo, Ontario, Canada

Nathalie Budd

Hoffmann-La Roche Limited, Mississauga, Ontario, Canada

Jennifer W Wu

Hoffmann-La Roche Limited, Mississauga, Ontario, Canada

Kerrie Schoffer

Division of Neurology, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia, Canada